Darren J. Buonocore

Ado-Trastuzumab Emtansine for Patients With <i>HER2</i>-Mutant Lung Cancers: Results From a Phase II Basket Trial

Bob T. Li, Ronglai Shen, Darren J. Buonocore et al. · Journal of Clinical Oncology · 2018 · 541 citations

Tumor Biology, Partial Response Rate, Medicine +14

SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization

Marina K. Baine, Min‐Shu Hsieh, W. Victoria Lai et al. · Journal of Thoracic Oncology · 2020 · 468 citations · Full text

Immunogenetics, Sclc Subtypes, Histopathologic Characterization +10

Structure and Distribution of an Unrecognized Interstitium in Human Tissues

Petros C. Benias, Rebecca G. Wells, Bridget Sackey-Aboagye et al. · Scientific Reports · 2018 · 340 citations · Full text

HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung Cancers

Bob T. Li, Flavia Michelini, Sandra Misale et al. · Cancer Discovery · 2020 · 274 citations · Full text

Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer

Corrin A. Wohlhieter, Allison L. Richards, Fathema Uddin et al. · Cell Reports · 2020 · 233 citations · Full text

Pathology, Cell Death, Scd1 Dependence +16